Back to Basics for Clinicians Series: Diagnosing and Managing Diabetes: A 21st Century Approach

The "Omics" technologies are a combination of genomic, proteomics, and metabolomics (including others) platforms which when integrate could researchers to diagnose rare diseases and provide a personalized disease management and or treatment. One of the initial limiting factors of these technologies has been their high cost, however the rapid decrease in cost of high-throughput technologies affords their use in clinics. The activity is designed to highlight the advances and application of omics in clinics for diagnosis of subtypes of type II diabetes and development of personalized disease management. The activity will introduce the attendees to a group of basic researchers and clinician who have used this approach in diagnosing and managing some diabetic patients with genetic variations.

Kindly note that this activity is targeted for Physicians. However, Researchers, Educators and other healthcare practitioners are welcome to attend.  The credit hours will be applicable only for Physicians as per QCHP Accreditation standards.

1. 1- Discuss new "Omics" technologies available for diagnosis of disease
2. 2- Describe application of "Omics" in diagnosis of diabetes subtypes
3. 3- Recognize the importance of understanding the genetic basis of diabetes for patient care
4. 4- Discuss the management of diabetes based on the "Omics" findings

QAR 50 or $ 14

Changes or Cancellations

• Name changes or substitutions are not permitted.
• All cancellation and refund requests must be made in writing and submitted via email to [email protected].
• For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
• We will attempt to process the refund within 30 days of receiving any cancellation request.
• Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 3.00 hour(s).

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Saturday, October 5, 2019